This procedure was adapted from prior reports.16,18 E. faecalis Lipid II (20 µM), PGT (0.5 µM), and bPBP (1 µM) were incubated in a 30 µL 1x reaction buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 30% DMSO) at 30 ºC for 1 h unless otherwise indicated. The reactions were heat-quenched at 95 ºC for 3 min and allowed to cool to room temperature. Polymerized material was digested by incubating the mixture at 37 ºC for 3 h after the addition of 65 µL ddH2O and 5 µL mutanolysin (from Streptomyces globisporus, 4000 U/mL). To reduce the muropeptide products, 50 µL sodium borohydride (10 mg/mL) was added and the mixture was incubated at room temperature for 30 min. The pH was adjusted to ~4 with 20% phosphoric acid and the samples were lyophilized to dryness overnight. The samples were resuspended in 20 µL ddH2O and analyzed by LC-MS on an Agilent 6520 Q-TOF mass spectrometer with ESI-MS operating in positive mode. Muropeptide products were separated on a Waters Symmetry Shield RP18 column (5 µm, 3.9 × 150 mm) with the following method: flow rate = 0.5 mL/min, 100% solvent A (H2O, 0.1% formic acid) for 5 min followed by a linear gradient of solvent B (acetonitrile, 0.1% formic acid) from 0 to 40% over 25 min. Molecular ions for the target muropeptide fragments were extracted from the total ion chromatogram.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.